We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

6 hedge funds and large institutions have $15.5M invested in Redhill Biopharma in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4,433% more capital invested

Capital invested by funds: $342K → $15.5M (+$15.2M)

500% more funds holding

Funds holding: 1 → 6 (+5)

Holders
6
Holders Change
+5
Holders Change %
+500%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
+$23M
2
O
OrbiMed
New York
+$8.47M
3
BC
Broadfin Capital
New York
+$3.52M
4
Wells Fargo
Wells Fargo
California
+$40.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$13.4K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$8.9M +$8.47M +632 New
BC
2
Broadfin Capital
New York
$3.71M +$3.52M +263 New
SFM
3
Sphera Funds Management
Israel
$2.43M +$23M +1,715 New
Goldman Sachs
4
Goldman Sachs
New York
$409K – – –
Wells Fargo
5
Wells Fargo
California
$42K +$40.2K +3 New
TRCT
6
Tower Research Capital (TRC)
New York
$11K +$13.4K +1 New
U
7
UBS
Switzerland
$4K – – –
Citigroup
8
Citigroup
New York
$1K – – –

RDHL Hedge Fund Activity: Q1 2014 in Review

6 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q1 2014, worth a combined $15.5M — up 4,433% from $342K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new RDHL positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sphera Funds Management, opening a new position worth an estimated $23M.

  • 6 institutional investors held Redhill Biopharma (RDHL) as of Q1 2014, up from 1 in Q4 2013.
  • Funds reported $15.5M of Redhill Biopharma stock for Q1 2014, up 4,433% quarter-over-quarter.
  • 5 funds opened new Redhill Biopharma positions in Q1 2014 and 0 closed out, a net change of +5 holders.
  • The largest Redhill Biopharma buyer in Q1 2014 was Sphera Funds Management, an estimated $23M added.

Based on aggregated 13F filings for Q1 2014.